Encompass Health Corporation (EHC) Tops Q1 EPS by 5c; Offers FY22 Guidance

Encompass Health Corporation (NYSE: EHC) reported Q1 EPS of $0.97, $0.05 better than the analyst estimate of $0.92. Revenue for the quarter came in at $1.33 billion versus the consensus estimate of $1.32 billion.

GUIDANCE:

Encompass Health Corporation sees FY2022 EPS of $3.83-$4.19, versus the consensus of $4.10. Encompass Health Corporation sees FY2022 revenue of $5.38-5.5 billion, versus the consensus of $5.45 billion.

For earnings history and earnings-related data on Encompass Health Corporation (EHC) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal
• Nike names former Pfizer CFO David Denton as new finance chief